title: Liposome-entrapped antifibrotic agent prevents collagen accumulation in hypertensive pulmonary arteries of rats.
abstract: We studied the therapeutic efficacy of an intravenously injected antifibrotic agent encapsulated in liposomes on inhibiting collagen accumulation in hypertensive blood vessels. cis-4-Hydroxy-L-proline (cHyp) in liposomes was injected into rats exposed to 10% O2, and drug effect was evaluated by measuring right ventricular pressure and hydroxyproline content of the pulmonary artery. Right ventricular pressure was 11 +/- 1 mm Hg (mean +/- SEM) 5 days after a single intravenous injection of 200 mg/kg cHyp in liposomes compared with 14 +/- 1 mm Hg in rats injected with empty liposomes; hydroxyproline content was also reduced by cHyp treatment (87 +/- 6 versus 107 +/- 7 micrograms per vessel) (p less than 0.05 for both, n = 6-9). Injections of cHyp in liposomes every 5 days partially prevented hypertension and vascular collagen accumulation during a 3-week exposure to hypoxia, and the dose required was one tenth the dose of unencapsulated cHyp. Therapeutic doses of cHyp in liposomes injected for 6 months affected tensile properties of main pulmonary artery and aorta, but there were no apparent histological effects on other organs. Liposomes injected intravenously were identified in pulmonary artery endothelial cells. The prolonged effect of a single injection of cHyp in liposomes may be due to uptake of the liposomes by the endothelium. Liposome delivery of drugs to the arterial wall may be useful in the study and treatment of hypertensive vascular disease.
authors.affiliation: Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway.
authors.forename: G J
authors.initials: GJ
authors.lastname: Poiani
authors.forename: F J
authors.initials: FJ
authors.lastname: Wilson
authors.forename: J D
authors.initials: JD
authors.lastname: Fox
authors.forename: J M
authors.initials: JM
authors.lastname: Sumka
authors.forename: B W
authors.initials: BW
authors.lastname: Peng
authors.forename: W C
authors.initials: WC
authors.lastname: Liao
authors.forename: C A
authors.initials: CA
authors.lastname: Tozzi
authors.forename: D J
authors.initials: DJ
authors.lastname: Riley
mesh_terms: D000818:Animals; D003094:Collagen / Q000378:metabolism*; D004337:Drug Carriers; D005355:Fibrosis; D006909:Hydroxyproline / Q000008:administration & dosage* / Q000378:metabolism; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008081:Liposomes; D008297:Male; D008854:Microscopy, Electron; D011651:Pulmonary Artery / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D003094:Collagen; D006909:Hydroxyproline